1. Home
  2. TCOM vs ZTS Comparison

TCOM vs ZTS Comparison

Compare TCOM & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCOM

Trip.com Group Limited

HOLD

Current Price

$47.69

Market Cap

33.0B

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$79.49

Market Cap

31.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCOM
ZTS
Founded
1999
1952
Country
Singapore
United States
Employees
43574
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.0B
31.2B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
TCOM
ZTS
Price
$47.69
$79.49
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$78.75
$154.18
AVG Volume (30 Days)
2.7M
9.2M
Earning Date
05-18-2026
05-07-2026
Dividend Yield
0.57%
1.86%
EPS Growth
N/A
10.05
EPS
N/A
1.42
Revenue
N/A
$9,467,000,000.00
Revenue This Year
$15.73
$5.63
Revenue Next Year
$13.00
$4.77
P/E Ratio
$9.06
$55.99
Revenue Growth
N/A
2.28
52 Week Low
$45.92
$73.82
52 Week High
$79.00
$169.50

Technical Indicators

Market Signals
Indicator
TCOM
ZTS
Relative Strength Index (RSI) 37.72 33.83
Support Level $45.92 $73.82
Resistance Level $54.37 $82.34
Average True Range (ATR) 1.06 2.54
MACD 0.03 1.44
Stochastic Oscillator 36.03 66.71

Price Performance

Historical Comparison
TCOM
ZTS

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: